DEVICOR MEDICAL PRODUCTS, INC. HYDROMARK BREAST BIOPSY SITE MARKER; BIOPSY SITE IDENTIFIER
|
Back to Search Results |
|
Model Number 4010-01-11-T3 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Hypersensitivity/Allergic reaction (1907)
|
Event Date 08/28/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
The hydromark breast biopsy site marker is used to mark tissue during a percutaneous breast biopsy procedure, be visible under ultrasound for at least 6 week, and be permanently by x-ray and mri.The device has not been returned for evaluation, which prevents a full investigation and analysis of a root cause at this time.However, this failure mode has been identified in the risk management file for the effects of potential hypersensitivity with a potential for injury to the patient and/or user.Follow up medical intervention may be necessary.Although it could not be concluded that our device caused or contributed to this event, through evaluation by our medical advisor on similar events, this has been determined to be reportable pursuant to 21 cfr 803.
|
|
Event Description
|
Devicor medical products inc.Received a report from affiliate, devicor medical (b)(4), stating, "placement of the hydromark biopsy site marker was completed on (b)(6) 2018.Physician had confirmed before the operation that the patient was not allergic.Patient presented to the er later at that night with such allergy symptoms as decrease in blood pressure and urticaria.Physician thinks the occurence of the event may have caused by either anesthetic or hydromark".The patient was given loxoprofen by mouth for pain related to the biopsy.Update on august 30, 2018, upon physical exam , the physician confirmed the urticaria resolved.The cause of the reaction was determined to be the xylocaine used in the procedure, not the hydromark.This has been documented in our complaint system as report (b)(4).
|
|
Search Alerts/Recalls
|
|
|